Biophore applies to DCGI for emergency-use approval for COVID-19 treatment drug

    50
    0

    The company plans to commence commercial production of the product immediately after the approval is received, the Hyderabad-based firm said.

    Drugmaker Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) seeking emergency use approval for Aviptadil Inhalation in the treatment of moderate to severe COVID-19.